Oramed Pharmaceuticals Inc. Beneficial Ownership Filing

This filing details Oramed Pharmaceuticals Inc.'s beneficial ownership of Lifeward Ltd. ordinary shares. The ownership is subject to various limitations based on the type of security and exercise terms. Specifically, pre-funded warrants are limited to 49.99% beneficial ownership, share purchase warrants are also limited to 49.99%, and purchase agreement warrants are limited to 45.0%. Senior secured convertible notes are also subject to a 45.0% beneficial ownership limitation. Oramed Pharmaceuticals Inc. holds a total of 1,250,363 ordinary shares directly. The filing also includes details on various warrants and convertible notes with specific exercise prices and underlying share amounts, all subject to the aforementioned beneficial ownership limitations.